Wearable medical device for patients with neurological conditions is now available for outpatient therapy
PHOTOS: https://f.io/vx0tOw6v
INTERVIEWS AND BROLL: https://f.io/3M_allac
FULL PRESS CONFERENCE: https://f.io/GCCVPu91
PITTSBURGH, Jan. 10, 2025 /PRNewswire-PRWeb/ -- When 13-year-old Mary Maloney suffered a rare spinal stroke following a trampoline accident in 2020, it was unclear if she'd ever be able to use her legs again. But with the aid of a new robotic exoskeleton, now available at Allegheny Health Network (AHN), Mary and other patients will have a renewed chance at mobility and independence.
AHN's EksoNR™ robotic exoskeleton, is a wearable full-body device that assists patients recovering from neurological injury or disease by providing them a tool to allow for weight-bearing therapeutic exercises that may not have been otherwise possible.
The EksoNR, manufactured by Ekso Bionics®, is the first robotic exoskeleton cleared by the FDA for use with stroke and spinal cord injury patients, and is the only one cleared for use with acquired brain injury and multiple sclerosis patients. This groundbreaking device is already revolutionizing outpatient rehabilitation for patients with neurological conditions.
"This has been a long and challenging journey for Mary," said Mary's mother, Pam Surano. "Witnessing the positive impact that the exoskeleton will have on her recovery and the lives of countless others is deeply moving. The accessibility of this cutting-edge technology right here in Pittsburgh is a true testament to the power of community support and the dedication of AHN."
AHN is now one of only two health care providers in the region to offer this innovative therapy, and the only location offering the technology for outpatient therapy use. AHN is also the only provider with the latest generation of EksoNR.
"This technology represents a significant leap forward in our ability to provide advanced rehabilitation services for patients with neurological conditions," said Donald Whiting, MD, chair of the AHN Neuroscience Institute. "The wearable robotic exoskeleton allows us to mobilize patients earlier in their recovery, leading to improved outcomes and enhanced quality of life."
The EksoNR's innovative software enables clinicians to personalize each rehabilitation session, adjusting settings to address individual patient needs and weaknesses. The goal is to help patients regain as much function as possible and, if possible, "walk out" of the device.
"It's crucial to manage expectations," said Gary Hoover, DO, Physical Medicine and Rehabilitation at AHN. "While the exoskeleton may not enable all patients to walk independently, its therapeutic benefits are significant. For patients recovering from acute neurological events, it can accelerate and enhance progress. For those with chronic conditions, it offers the vital advantages of weight-bearing and standing activities in therapy, which is crucial to help manage complications of chronic neurologic injuries."
The acquisition of the EksoNR was made possible through generous donations totaling over $200,000, including significant contributions from the West Penn Hospital Foundation, and Miracles for Mary.
Miracles for Mary was created following Mary's 2020 trampoline accident, which resulted in a spinal stroke that led to paralysis from the chest down. Since then, the Wexford teen has undergone extensive rehabilitation at various in-state and out-of-state hospitals, striving to regain her ability to walk. To bring advanced care closer to home, Mary's family and friends, through the Miracles for Mary Foundation, raised funds to purchase a robotic exoskeleton for her use and the benefit of other patients in Pittsburgh.
The rarity of spinal strokes — accounting for just over 1% of all strokes, according to the American Heart Association — highlights the significance of this new local resource for Mary and other patients who have experienced neurological injuries.
"The EksoNR offers our patients a tool to achieve greater independence," said Mary McDunn PT, Regional Manager, Outpatient Rehabilitation Services at AHN. "For some, it may accelerate their recovery and help them relearn proper gait patterns. For others, it will provide the invaluable benefits of weight-bearing and standing, improving overall health and well-being."
AHN's EksoNR is located at the Network's AHN Suburban facility in Bellevue and is fully operational for outpatient rehabilitation. Physician referral and approval are required for use. For more information about AHN's therapy services and outpatient rehabilitation clinics, please visit the website or call 412-734-6030.
About Allegheny Health Network
Allegheny Health Network (AHN.org) is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network comprises 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, multiple employed physician organizations, home and community-based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women's health, diabetes, autoimmune disease and more. AHN employs approximately 23,000 people, has more than 2,500 physicians on its medical staff, and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.
About Ekso Bionics®
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the company continues to build upon its unparalleled expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The company is headquartered in the Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO. For more information, visit: http://www.eksobionics.com or follow us on social media platforms @eksobionics.
Media Contact
Sarafina Brooks James, https://www.ahn.org, 412-609-2902, [email protected], https://www.ahn.org/newsroom
SOURCE Allegheny Health Network
Share this article